Daily non-political popular news in brief.

New inhibitor has potential as cancer drug

Laboratory experiments have previously shown that cancer cells overproduce an enzyme, heparanase, which splits the body's own polysaccharide heparan sulfate into shorter fragments. The amount of enzyme is related to the degree of malignancy. Today a study is being published in the journal Nature Chemical Biology in which Uppsala University researchers show, on the basis of animal models, that an inhibitor for heparanase would be extremely interesting as a drug candidate.

Read more »

Keywords: inhibitor, potential, cancer, drug

« Previous | Next »

Similar news on "New inhibitor has potential as cancer drug":

1. New angiogenesis inhibitor has promise for treating deadly brain tumor
   01-16-2007 · EurekAlert!
   Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
   Similar news · Read more »
   
2. Other highlights in the Jan. 8 JNCI
   01-08-2008 · EurekAlert!
   Also in the Jan. 8 JNCI are an association between statin use and reduced cancer risk, a potential colon cancer drug target, a mouse model for studying kidney cancer, and a review of how tumor viruses regulate telomeres.
   Similar news · Read more »
   
3. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
   01-21-2008 · EurekAlert!
   Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
   Similar news · Read more »
   
4. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
5. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
   06-27-2007 · EurekAlert!
   Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
   Similar news · Read more »
   
6. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
   11-08-2006 · EurekAlert!
   Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague.
   Similar news · Read more »
   
7. Pros, cons of drug proven to prevent prostate cancer should be considered, UT Southwestern researchers recommend
   01-21-2008 · UT Southwestern Medical Center
   Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
   Similar news · Read more »
   
8. Impaired Gene Helps Nonsmall-cell Lung Cancer Resist Drug
   10-02-2006 · ScienceDaily
   Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease, researchers at the University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center at Dallas report in the cover article of the Oct. 1 edition of Cancer Research.
   Similar news · Read more »
   
9. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
   04-09-2007 · EurekAlert!
   Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
   Similar news · Read more »
   
10. Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
    10-23-2006 · EurekAlert!
    While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
    Similar news · Read more »